1st Faculty of Medicine Charles University 1st Faculty of Medicine Charles University Inst. of Biochemistry and Experimental Oncology
mszta 09.04.2025

People

  1108

 

Dr. Martin Sztacho began his scientific career at Charles University in Prague, investigating regulatory pathways of metastatic sarcoma cell invasiveness in Prof. Jan Brábek’s lab. He pursued a Ph.D. through the Max Planck Institute’s international program in Dresden, where he studied podosomes in osteoclasts under Prof. Bernard Hoflack, linking these structures to invadopodia involved in cancer cell invasion. Following this, Dr. Sztacho joined Prof. Sascha Martens’ lab at Max Perutz Labs in Vienna, foc

1109using on the molecular mechanisms of autophagy and its role in cancer progression. In 2017, he returned to Prague to work with Prof. Pavel Hozák at the Institute of Molecular Genetics, where he explored the role of nuclear phosphoinositides in gene expression regulation and nuclear architecture, particularly in the context of RNA Polymerase II transcription. His current research focuses on the mechanisms of phase separation driving the formation of biomolecular condensates that contribute to the spatiotemporal organization of intracellular architecture in cancer cells. 








1107 Dr. Agnieszka Chytła started her scientific journey at the University of Wroclaw in Poland, where, during her master's studies and continuing through her PhD, she delved into understanding the detailed mechanism of membrane raft organisation, with a particular emphasis on the role of the MPP1 protein in stabilising flotillin nanodomains. She defended her PhD thesis in 2023 and has been a postdoctoral fellow at the Institute of Biochemistry and Experimental Oncology since April 2024. Her current work focuses on understanding how phosphoinositides and RNA contribute to phase separation, and how this process shapes cellular organisation and impacts disease







1110









  MSc. Elena Herencia Lagunar holds a degree in Veterinary Medicine and a Masters in Virology. With a strong interdisciplinary background, she has gained extensive experience in molecular biology and d 1111iagnostics. She is currently pursuing a PhD in cancer cell biology, focusing on the formation and function of glycolytic condensates in glioblastoma cells under hypoxic conditions. She uses protein purification, mass spectrometry and advanced microscopy to study molecular composition and spatial dynamics within the cell. Her work aims to elucidate how biomolecular condensates contribute to metabolic adaptation in low-oxygen environment, providing insights into cancer cell physiology and potential new therapeutic strategies.










MSc. Rabia Gonul completed her undergraduate studies in Genetics and Bioengineering at Istanbul Bilgi University in 2019, where she studied molecular biology, genetic engineering, bioinformatics, and biochemistry. She earned her Master’s degree in Biological Sciences from Ege University in 2022, focusing on the molecular mechanisms underlying the relationship between circadian rhythm and GABA biosynthesis. Rabia’s Ph

1112D project investigates the impact of nuclear phosphatidylinositol 4,5-bisphosphate (PIP2) manipulation on transcriptional regulation in cancer cells. She is developing an inducible system to selectively reduce nuclear PIP2 levels in order to investigate its role in transcriptional regulation during cancer progression.









1113

 

number of views: 39 author: mszta, last modification: mszta, 09.04.2025
Page ranking: If you think the article is not up-to-date, click here.